154 related articles for article (PubMed ID: 33389298)
1. Clinical Outcomes After Urinary Diversion for Malignant Ureteral Obstruction Secondary to Non-urologic Cancer: An Analysis of 778 Cases.
Heo JE; Jeon DY; Lee J; Ham WS; Choi YD; Jang WS
Ann Surg Oncol; 2021 Apr; 28(4):2367-2373. PubMed ID: 33389298
[TBL] [Abstract][Full Text] [Related]
2. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
[TBL] [Abstract][Full Text] [Related]
3. Management of extrinsic malignant ureteral obstruction with urinary diversion.
Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for overall survival in malignant ureteral obstruction.
Mason JB; Creswell M; Egan J; Dall C; Sholklapper T; Galloway LA; Orzel J; Lee H; Desale S; Stamatakis L
Can J Urol; 2022 Jun; 29(3):11162-11169. PubMed ID: 35691038
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Stent Failure for Malignant Ureteral Obstruction in Non-Urological Cancer.
Heo JE; Jeon DY; Lee J; Han HH; Jang WS
Yonsei Med J; 2023 Nov; 64(11):665-669. PubMed ID: 37880847
[TBL] [Abstract][Full Text] [Related]
6. Palliative percutaneous and endoscopic urinary diversion for malignant ureteral obstruction.
Gasparini M; Carroll P; Stoller M
Urology; 1991 Nov; 38(5):408-12. PubMed ID: 1719688
[TBL] [Abstract][Full Text] [Related]
7. [Management of ureteral obstruction : Value of percutaneous nephrostomy and ureteral stents].
Netsch C; Becker B; Gross AJ
Urologe A; 2016 Nov; 55(11):1497-1510. PubMed ID: 27787581
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome and management of ureteral obstruction secondary to gastric cancer.
Migita K; Watanabe A; Samma S; Ohyama T; Ishikawa H; Kagebayashi Y
World J Surg; 2011 May; 35(5):1035-41. PubMed ID: 21387134
[TBL] [Abstract][Full Text] [Related]
9. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients.
Cordeiro MD; Coelho RF; Chade DC; Pessoa RR; Chaib MS; Colombo-Júnior JR; Pontes-Júnior J; Guglielmetti GB; Srougi M
BJU Int; 2016 Feb; 117(2):266-71. PubMed ID: 25327474
[TBL] [Abstract][Full Text] [Related]
10. Predictors of antegrade ureteral stenting failure: a single-center experience in patients with malignant and benign ureteral obstruction.
Nas OF; Oztepe MF; Kandemirli SG; Bilgin C; Ozkaya G; Inecikli MF; Kaygısız O
Abdom Radiol (NY); 2021 May; 46(5):2188-2194. PubMed ID: 33226456
[TBL] [Abstract][Full Text] [Related]
11. Outcome of Palliative Urinary Diversion and Observation for Malignant Extrinsic Ureteral Obstruction.
Tatenuma T; Tsutsumi S; Yasui M; Noguchi G; Umemoto S; Kishida T
J Palliat Med; 2020 Feb; 23(2):254-258. PubMed ID: 31834827
[No Abstract] [Full Text] [Related]
12. Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies.
Barton DP; Morse SS; Fiorica JV; Hoffman MS; Roberts WS; Cavanagh D
Obstet Gynecol; 1992 Nov; 80(5):805-11. PubMed ID: 1407920
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of ureteral obstruction in primary cervical cancer.
Lee SK; Jones HW
Int J Gynaecol Obstet; 1994 Jan; 44(1):59-65. PubMed ID: 7907060
[TBL] [Abstract][Full Text] [Related]
14. Nonoperative urinary diversion for malignant ureteral obstruction.
Zadra JA; Jewett MA; Keresteci AG; Rankin JT; St Louis E; Grey RR; Pereira JJ
Cancer; 1987 Sep; 60(6):1353-7. PubMed ID: 3621117
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of stent-change therapy for bilateral malignancy-related ureteral obstruction.
Song SH; Pak S; Jeong IG; Kim KS; Park HK; Kim CS; Ahn H; Hong B
Int Urol Nephrol; 2015 Jan; 47(1):19-24. PubMed ID: 25315466
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcomes of Double-Layered Polytetrafluoroethylene Membrane-Covered Self-Expandable Segmental Metallic Stents (Uventa) in Patients with Chronic Ureteral Obstructions: Is It Really Safe?
Kim M; Hong B; Park HK
J Endourol; 2016 Dec; 30(12):1339-1346. PubMed ID: 27736158
[TBL] [Abstract][Full Text] [Related]
17. Palliative Subcutaneous Tunneled Nephrostomy Tube (PSTN): a simple and effective technique for management of malignant extrinsic ureteral obstruction.
Bell DG; Fischer MA
Can J Urol; 2002 Feb; 9(1):1470-4. PubMed ID: 11886602
[TBL] [Abstract][Full Text] [Related]
18. Tandem Ureteral Stents for Malignant Ureteral Obstruction.
Haifler M; Shvero A; Zilberman D; Ramon J; Winkler H; Margel D; Kleinmann N
J Endourol; 2020 Feb; 34(2):222-226. PubMed ID: 31724450
[No Abstract] [Full Text] [Related]
19. The challenging management of malignant ureteral obstruction: Analysis of a series of 188 cases.
Artiles Medina A; Laso García I; González Tello F; Álvarez Rodríguez S; Hevia Palacios M; Mata Alcaraz M; Mínguez Ojeda C; Arias Funez F; Gómez Dos Santos V; Burgos Revilla FJ
Curr Urol; 2024 Mar; 18(1):34-42. PubMed ID: 38505156
[TBL] [Abstract][Full Text] [Related]
20. Outcome of palliative urinary diversion in the treatment of advanced malignancies.
Shekarriz B; Shekarriz H; Upadhyay J; Banerjee M; Becker H; Pontes JE; Wood DP
Cancer; 1999 Feb; 85(4):998-1003. PubMed ID: 10091780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
